DTG/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children With HIV Infection Aged 2 to <15 Years Old
Clinical trial NCT04337450 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04337450
- Sponsor
- PENTA Foundation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-22
- Primary completion
- 2025-09-30
- Enrollment
- 386
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.